Role of Neutralizing Antibodies in the Prediction and Treatment of BK Virus Infection in Hematopoietic Stem Cell Allograft Patients at the Pediatric Oncology-hematology Department of the HUS
Clinical trial NCT05618275 · UNKNOWN
Trial details
- NCT number
- NCT05618275
- Sponsor
- University Hospital, Strasbourg, France
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2020-01-01
- Primary completion
- 2022-12-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.